We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Caspase-3 Identified as the Key Biomarker for Apoptosis

Promega Homogeneous Bioluminescent Caspase Assays simplify apoptosis detection and are up to 50-100 times more sensitive than competitive caspase technologies. Now, detect caspase-3/7, -8, -9, -2 and -6 activities in multiwell plates using less cells or enzyme and get faster throughput, with same-well multiplexing capability to determine the mechanism of cell death.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.